Main > ONCOLOGY (**) > Ovarian Cancer Advanced HRD+>

---

Ovarian Cancer Advanced HRD+>'s subsections
(*) CN Approval Date: 2022. 09.22
>1st Line Maintenance Treat.>
Company
PARP Inhibitor Generic Name
RTM
RTM Web-Site
USA Patent Numbers

Ovarian Cancer Advanced HRD+>'s products
This section has no products